FDA Inspection 1286076 — Octapharma Plasma, Inc.

Octapharma Plasma, Inc. — FEI 3014027617

The FDA completed an inspection of Octapharma Plasma, Inc. on Oct 8, 2025 in West Palm Beach, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Oct 8, 2025
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
West Palm Beach, FL (United States)

Need the full FDA record for Octapharma Plasma, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.